Evaluation of carbapenemase screening and confirmation tests with Enterobacteriaceae and development of a practical diagnostic algorithm

Journal of Clinical Microbiology

Volumn 53, Issue 1, 2015, Pages 95-104

  Maurer, Florian P ^a   Castelberg, Claudio ^a   Quiblier, Chantal ^a   Bloemberg, Guido V ^a   Hombach, Michael ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPHENYLBORONIC ACID; BETA LACTAMASE AMPC; BORONIC ACID DERIVATIVE; CARBAPENEMASE; EDETIC ACID; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; MEROPENEM; TEMOCILLIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE;

ALGORITHM; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL TRANSMISSION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CLINICAL LABORATORY; CONTROLLED STUDY; DISK DIFFUSION; DRUG SCREENING; ENTEROBACTERIACEAE; ENZYME ANALYSIS; ENZYME ASSAY; GENETIC ANALYSIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY; CLASSIFICATION; DISEASE MANAGEMENT; DRUG EFFECTS; ENTEROBACTERIACEAE INFECTIONS; GENETICS; GENOTYPE; HUMAN; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTILOCUS SEQUENCE TYPING; REPRODUCIBILITY;

ENTEROBACTERIACEAE;

ALGORITHMS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; DISEASE MANAGEMENT; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; MULTILOCUS SEQUENCE TYPING; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84919469661     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01692-14     Document Type: Article

References (57)

1. Bush K, Fisher JF. 2011. Epidemiological expansion, structural studies, and clinical challenges of new beta-lactamases from Gram-negative bacteria. Annu Rev Microbiol 65:455-478. http://dx.doi.org/10.1146/annurev-micro-090110-102911.
2. Hirsch EB, Tam VH. 2010. Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection. J Antimicrob Chemother 65:1119-1125. http://dx.doi.org/10.1093/jac/dkq108.
3. Leski T, Vora GJ, Taitt CR. 2012. Multidrug resistance determinants from NDM-1-producing Klebsiella pneumoniae in the USA. Int J Antimicrob Agents 40:282-284. http://dx.doi.org/10.1016/j.ijantimicag.2012.05.019.
4. Kelesidis T, Karageorgopoulos DE, Kelesidis I, Falagas ME. 2008. Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies. J Antimicrob Chemother 62:895-904. http://dx.doi.org/10.1093/jac/dkn311.
5. Bush K. 2013. The ABCD's of beta-lactamase nomenclature. J Infect Chemother 19:549-559. http://dx.doi.org/10.1007/s10156-013-0640-7.
6. Queenan AM, Bush K. 2007. Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev 20:440-458. http://dx.doi.org/10.1128/CMR.00001-07.
7. Munoz-Price LS, Poirel L, Bonomo RA, Schwaber MJ, Daikos GL, Cormican M, Cornaglia G, Garau J, Gniadkowski M, Hayden MK, Kumarasamy K, Livermore DM, Maya JJ, Nordmann P, Patel JB, Paterson DL, Pitout J, Villegas MV, Wang H, Woodford N, Quinn JP. 2013. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis 13:785-796. http://dx.doi.org/10.1016/S1473-3099(13)70190-7.
8. Cantón R, Akova M, Carmeli Y, Giske CG, Glupczynski Y, Gniadkowski M, Livermore DM, Miriagou V, Naas T, Rossolini GM, Samuelsen O, Seifert H, Woodford N, Nordmann P, European Network on Carbapenemases. 2012. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect 18:413-431. http://dx.doi.org/10.1111/j.1469-0691.2012.03821.x.
9. Potron A, Poirel L, Rondinaud E, Nordmann P. 2013. Intercontinental spread of OXA-48 beta-lactamase-producing Enterobacteriaceae over a 11-year period, 2001 to 2011. Euro Surveill 18:20549. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId 20549.
10. Girlich D, Poirel L, Nordmann P. 2013. Comparison of the SUPERCARBA, CHROMagar KPC, and Brilliance CRE screening media for detection of Enterobacteriaceae with reduced susceptibility to carbapenems. Diagn Microbiol Infect Dis 75:214-217. http://dx.doi.org/10.1016/j.diagmicrobio.2012.10.006.
11. Hornsey M, Phee L, Woodford N, Turton J, Meunier D, Thomas C, Wareham DW. 2013. Evaluation of three selective chromogenic media, CHROMagar ESBL, CHROMagar CTX-M and CHROMagar KPC, for the detection of Klebsiella pneumoniae producing OXA-48 carbapenemase. J Clin Pathol 66:348-350. http://dx.doi.org/10.1136/jclinpath-2012-201234.
12. Papadimitriou-Olivgeris M, Bartzavali C, Christofidou M, Bereksi N, Hey J, Zambardi G, Spiliopoulou I. 2014. Performance of chromID(R) CARBA medium for carbapenemases-producing Enterobacteriaceae detection during rectal screening. Eur J Clin Microbiol Infect Dis 33:35-40. http://dx.doi.org/10.1007/s10096-013-1925-6.
13. Seah C, Low DE, Patel SN, Melano RG. 2011. Comparative evaluation of a chromogenic agar medium, the modified Hodge test, and a battery of meropenem-inhibitor discs for detection of carbapenemase activity in Enterobacteriaceae. J Clin Microbiol 49:1965-1969. http://dx.doi.org/10.1128/JCM.00203-11.
14. European Committee on Antimicrobial Susceptibility Testing. 2013. Guidelines for detection of resistance mechanisms and specific resistances of clinical and/or epidemiological importance. Version 1.0. European Committee on Antimicrobial Susceptibility Testing, Basel, Switzerland. http://www.eucast.org/resistance-mechanisms/. Accessed 16 June 2014.
15. Tenover FC, Canton R, Kop J, Chan R, Ryan J, Weir F, Ruiz-Garbajosa P, LaBombardi V, Persing DH. 2013. Detection of colonization by carbapenemase-producing Gram-negative bacilli in patients by use of the Xpert MDRO assay. J Clin Microbiol 51:3780-3787. http://dx.doi.org/10.1128/JCM.01092-13.
16. Poirel L, Walsh TR, Cuvillier V, Nordmann P. 2011. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis 70:119-123. http://dx.doi.org/10.1016/j.diagmicrobio.2010.12.002.
17. Cuzon G, Naas T, Bogaerts P, Glupczynski Y, Nordmann P. 2012. Evaluation of a DNA microarray for the rapid detection of extended-spectrum beta-lactamases (TEM, SHV and CTX-M), plasmid-mediated cephalosporinases (CMY-2-like, DHA, FOX, ACC-1, ACT/MIR and CMY-1-like/MOX) and carbapenemases (KPC, OXA-48, VIM, IMP and NDM). J Antimicrob Chemother 67:1865-1869. http://dx.doi.org/10.1093/jac/dks156.
18. Doern CD, Dunne WM, Jr, Burnham CA. 2011. Detection of Klebsiella pneumoniae carbapenemase (KPC) production in non-Klebsiella pneumoniae Enterobacteriaceae isolates by use of the Phoenix, Vitek 2, and disk diffusion methods. J Clin Microbiol 49:1143-1147. http://dx.doi.org/10.1128/JCM.02163-10.
19. Pasteran F, Mendez T, Guerriero L, Rapoport M, Corso A. 2009. Sensitive screening tests for suspected class A carbapenemase production in species of Enterobacteriaceae. J Clin Microbiol 47:1631-1639. http://dx.doi.org/10.1128/JCM.00130-09.
20. Willems E, Verhaegen J, Magerman K, Nys S, Cartuyvels R. 2013. Towards a phenotypic screening strategy for emerging beta-lactamases in Gram-negative bacilli. Int J Antimicrob Agents 41:99-109. http://dx.doi.org/10.1016/j.ijantimicag.2012.07.006.
21. Doyle D, Peirano G, Lascols C, Lloyd T, Church DL, Pitout JD. 2012. Laboratory detection of Enterobacteriaceae that produce carbapenemases. J Clin Microbiol 50:3877-3880. http://dx.doi.org/10.1128/JCM.02117-12.
22. Giske CG, Gezelius L, Samuelsen O, Warner M, Sundsfjord A, Woodford N. 2011. A sensitive and specific phenotypic assay for detection of metallo-beta-lactamases and KPC in Klebsiella pneumoniae with the use of meropenem disks supplemented with aminophenylboronic acid, dipicolinic acid and cloxacillin. Clin Microbiol Infect 17:552-556. http://dx.doi.org/10.1111/j.1469-0691.2010.03294.x.
23. Clinical and Laboratory Standards Institute. 2014. Performance standards for antimicrobial susceptibility testing; twenty-fourth informational supplement. CLSI document M100-S24. CLSI, Wayne, PA.
24. Tsakris A, Poulou A, Pournaras S, Voulgari E, Vrioni G, Themeli-Digalaki K, Petropoulou D, Sofianou D. 2010. A simple phenotypic method for the differentiation of metallo-beta-lactamases and class A KPC carbapenemases in Enterobacteriaceae clinical isolates. J Antimicrob Chemother 65:1664-1671. http://dx.doi.org/10.1093/jac/dkq210.
25. van Dijk K, Voets GM, Scharringa J, Voskuil S, Fluit AC, Rottier WC, Leverstein-Van Hall MA, Cohen Stuart JW. 2014. A disc diffusion assay for detection of class A, B and OXA-48 carbapenemases in Enterobacteriaceae using phenyl boronic acid, dipicolinic acid and temocillin. Clin Microbiol Infect 20:345-349. http://dx.doi.org/10.1111/1469-0691.12322.
26. Dortet L, Poirel L, Nordmann P. 2012. Rapid identification of carbapenemase types in Enterobacteriaceae and Pseudomonas spp. by using a biochemical test. Antimicrob Agents Chemother 56:6437-6440. http://dx.doi.org/10.1128/AAC.01395-12.
27. Nordmann P, Poirel L, Dortet L. 2012. Rapid detection of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 18:1503-1507. http://dx.doi.org/10.3201/eid1809.120355.
28. Huang TD, Berhin C, Bogaerts P, Glupczynski Y. 2014. Comparative evaluation of two chromogenic tests for the rapid detection of carbapenemase in Enterobacteriaceae and in Pseudomonas aeruginosa isolates. J Clin Microbiol 52:3060-3063. http://dx.doi.org/10.1128/JCM.00643-14.
29. NDM by use of multiplex real-time PCR. J Clin Microbiol 51:1247-1249. http://dx.doi.org/10.1128/JCM.03316-12.
30. Dortet L, Poirel L, Nordmann P. 2014. Further proofs of concept for the Carba NP test. Antimicrob Agents Chemother 58:1269. http://dx.doi.org/10.1128/AAC.01825-13.
31. Tijet N, Boyd D, Patel SN, Mulvey MR, Melano RG. 2013. Evaluation of the Carba NP test for rapid detection of carbapenemase-producing Enterobacteriaceae and Pseudomonas aeruginosa. Antimicrob Agents Chemother 57:4578-4580. http://dx.doi.org/10.1128/AAC.00878-13.
32. Vasoo S, Cunningham SA, Kohner PC, Simner PJ, Mandrekar JN, Lolans K, Hayden MK, Patel R. 2013. Comparison of a novel, rapid chromogenic biochemical assay, the Carba NP test, with the modified Hodge test for detection of carbapenemase-producing Gram-negative bacilli. J Clin Microbiol 51:3097-3101. http://dx.doi.org/10.1128/JCM.00965-13.
33. Yusuf E, Van Der Meeren S, Schallier A, Pierard D. 10 July 2014. Comparison of the Carba NP test with the Rapid CARB Screen kit for the detection of carbapenemase-producing Enterobacteriaceae and Pseudomonas aeruginosa. Eur J Clin Microbiol Infect Dis http://dx.doi.org/10.1007/s10096-014-2199-3.
34. Dortet L, Brechard L, Poirel L, Nordmann P. 2014. Impact of the isolation medium for detection of carbapenemase-producing Enterobacteriaceae using an updated version of the Carba NP test. J Med Microbiol 63:772-776. http://dx.doi.org/10.1099/jmm.0.071340-0.
35. Peter S, Lacher A, Marschal M, Holzl F, Buhl M, Autenrieth I, Kaase M, Willmann M. 2014. Evaluation of phenotypic detection methods for metallo-beta-lactamases (MBLs) in clinical isolates of Pseudomonas aeruginosa. Eur J Clin Microbiol Infect Dis 33:1133-1141. http://dx.doi.org/10.1007/s10096-014-2059-1.
36. Tijet N, Boyd D, Patel SN, Mulvey MR, Melano RG. 2014. Reply to "further proofs of concept for the Carba NP test." Antimicrob Agents Chemother 58:1270. http://dx.doi.org/10.1128/AAC.02285-13.
37. Doumith M, Ellington MJ, Livermore DM, Woodford N. 2009. Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK. J Antimicrob Chemother 63:659-667. http://dx.doi.org/10.1093/jac/dkp029.
38. Elliott E, Brink AJ, van Greune J, Els Z, Woodford N, Turton J, Warner M, Livermore DM. 2006. In vivo development of ertapenem resistance in a patient with pneumonia caused by Klebsiella pneumoniae with an ex-tended-spectrum beta-lactamase. Clin Infect Dis 42:e95-98. http://dx.doi.org/10.1086/503264.
39. Fernández-Cuenca F, Rodriguez-Martinez JM, Martinez-Martinez L, Pascual A. 2006. In vivo selection of Enterobacter aerogenes with reduced susceptibility to cefepime and carbapenems associated with decreased expression of a 40 kDa outer membrane protein and hyperproduction of AmpC beta-lactamase. Int J Antimicrob Agents 27:549-552. http://dx.doi.org/10.1016/j.ijantimicag.2006.01.005.
40. García-Sureda L, Domenech-Sanchez A, Barbier M, Juan C, Gasco J, Alberti S. 2011. OmpK26, a novel porin associated with carbapenem resistance in Klebsiella pneumoniae. Antimicrob Agents Chemother 55: 4742-4747. http://dx.doi.org/10.1128/AAC.00309-11.
41. Guillon H, Tande D, Mammeri H. 2011. Emergence of ertapenem resistance in an Escherichia coli clinical isolate producing extended-spectrum beta-lactamase AmpC. Antimicrob Agents Chemother 55:4443-4446. http://dx.doi.org/10.1128/AAC.01513-10.
42. Lee YT, Chen TL, Siu LK, Chen CP, Fung CP. 2011. Impact of derepressed AmpC beta-lactamase ACT-9 on the clinical efficacy of ertapenem. Antimicrob Agents Chemother 55:4440-4442. http://dx.doi.org/10.1128/AAC.00271-11.
43. Mammeri H, Nordmann P, Berkani A, Eb F. 2008. Contribution of extended-spectrum AmpC (ESAC) beta-lactamases to carbapenem resistance in Escherichia coli. FEMS Microbiol Lett 282:238-240. http://dx.doi.org/10.1111/j.1574-6968.2008.01126.x.
44. Skurnik D, Nucci A, Ruimy R, Lasocki S, Muller-Serieys C, Montravers P, Andremont A, Courvalin P. 2010. Emergence of carbapenem-resistant Hafnia: the fall of the last soldier. Clin Infect Dis 50:1429-1431. http://dx.doi.org/10.1086/652289.
45. Hartl R, Widhalm S, Kerschner H, Apfalter P. 2013. Temocillin and meropenem to discriminate resistance mechanisms leading to decreased carbapenem susceptibility with focus on OXA-48 in Enterobacteriaceae. Clin Microbiol Infect 19:E230-232. http://dx.doi.org/10.1111/1469-0691.12146.
46. Poirel L, Naas T, Nordmann P. 2010. Diversity, epidemiology, and genetics of class D beta-lactamases. Antimicrob Agents Chemother 54:24-38. http://dx.doi.org/10.1128/AAC.01512-08.
47. Polsfuss S, Bloemberg GV, Giger J, Meyer V, Bottger EC, Hombach M. 2011. Practical approach for reliable detection of AmpC beta-lactamaseproducing Enterobacteriaceae. J Clin Microbiol 49:2798-2803. http://dx.doi.org/10.1128/JCM.00404-11.
48. Polsfuss S, Bloemberg GV, Giger J, Meyer V, Bottger EC, Hombach M. 2012. Evaluation of a diagnostic flow chart for detection and confirmation of extended spectrum beta-lactamases (ESBL) in Enterobacteriaceae. Clin Microbiol Infect 18:1194-1204.
49. Poirel L, Potron A, Nordmann P. 2012. OXA-48-like carbapenemases: the phantom menace. J Antimicrob Chemother 67:1597-1606. http://dx.doi.org/10.1093/jac/dks121.
50. Bloemberg GV, Polsfuss S, Meyer V, Bottger EC, Hombach M. 2014. Evaluation of the AID ESBL line probe assay for rapid detection of extended-spectrum beta-lactamase (ESBL) and KPC carbapenemase genes in Enterobacteriaceae. J Antimicrob Chemother 69:85-90. http://dx.doi.org/10.1093/jac/dkt345.
51. Pérez-Pérez FJ, Hanson ND. 2002. Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 40:2153-2162. http://dx.doi.org/10.1128/JCM.40.6.2153-2162.2002.
52. Peter-Getzlaff S, Polsfuss S, Poledica M, Hombach M, Giger J, Böttger EC, Zbinden R, Bloemberg GV. 2011. Detection of AmpC beta-lactamase in Escherichia coli: comparison of three phenotypic confirmation assays and genetic analysis. J Clin Microbiol 49:2924-2932. http://dx.doi.org/10.1128/JCM.00091-11.
53. European Committee on Antimicrobial Susceptibility Testing. 2014. Disk diffusion manual v. 3.0. European Committee on Antimicrobial Susceptibility Testing, Basel, Switzerland. http://www.eucast.org/eucast-susceptibility-testing/disk-diffusion-methodology. Accessed 11 June 2014.
54. Jacoby GA. 2009. AmpC beta-lactamases. Clin Microbiol Rev 22:161-182. http://dx.doi.org/10.1128/CMR.00036-08.
55. Pasteran F, Lucero C, Soloaga R, Rapoport M, Corso A. 2011. Can we use imipenem and meropenem Vitek 2 MICs for detection of suspected KPC and other-carbapenemase producers among species of Enterobacteriaceae? J Clin Microbiol 49:697-701. http://dx.doi.org/10.1128/JCM.01178-10.
56. Cai JC, Hu YY, Zhang R, Zhou HW, Chen GX. 2012. Detection of OmpK36 porin loss in Klebsiella spp. by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 50:2179-2182. http://dx.doi.org/10.1128/JCM.00503-12.
57. Pournaras S, Poulou A, Tsakris A. 2010. Inhibitor-based methods for the detection of KPC carbapenemase-producing Enterobacteriaceae in clinical practice by using boronic acid compounds. J Antimicrob Chemother 65: 1319-1321. http://dx.doi.org/10.1093/jac/dkq124.